Global Norepinephrine (Noradrenaline) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082418652

Publication Date:

August 30, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is an organic chemical in the catecholamine family that functions in the brain and body as a hormone and neurotransmitter. Norepinephrine also called noradrenaline is both a hormone, produced by the adrenal glands, and a neurotransmitter, a chemical messenger which transmits signals across nerve endings in the body. Norepinephrine is produced in the inner part of the adrenal glands, also called the adrenal medulla. The adrenal medulla also makes adrenaline (also known as epinephrine). Norepinephrine, adrenaline and dopamine belong are part of the catecholamine family. Adrenal glands are making primarily adrenaline and most of the norepinephrine in the blood comes from nerve endings. It plays a role in your mood and ability to concentrate.
The global Norepinephrine (Noradrenaline) market size was valued at US$ 461 million in 2023 and is forecast to a readjusted size of USD 981 million by 2030 with a CAGR of 11.5% during review period.
Global Norepinephrine/Noradrenaline key players include Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, etc. Global top five manufacturers hold a share over 55%. America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe, total have a share over 45 percent. In terms of product, 4mg is the largest segment, with a share over 70%. And in terms of application, the largest application is AMI Hypotension, followed by Shock Hypotensive.
This report is a detailed and comprehensive analysis for global Norepinephrine (Noradrenaline) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Norepinephrine (Noradrenaline) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Norepinephrine (Noradrenaline) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Norepinephrine (Noradrenaline) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Norepinephrine (Noradrenaline) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Norepinephrine (Noradrenaline)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Norepinephrine (Noradrenaline) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest, Grand Pharmaceutical, King York, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Norepinephrine (Noradrenaline) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Norepinephrine (Noradrenaline) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2mg
4mg
Other
Market segment by Application
Shock Hypotensive
AMI Hypotension
Other
Market segment by players, this report covers
Pfizer
Novartis
Teva
Amneal Biosciences
Baxter
Mylan
Hikma Pharmaceuticals
Shanghai Harvest
Grand Pharmaceutical
King York
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Norepinephrine (Noradrenaline) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Norepinephrine (Noradrenaline), with revenue, gross margin, and global market share of Norepinephrine (Noradrenaline) from 2019 to 2024.
Chapter 3, the Norepinephrine (Noradrenaline) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Norepinephrine (Noradrenaline) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Norepinephrine (Noradrenaline).
Chapter 13, to describe Norepinephrine (Noradrenaline) research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Norepinephrine (Noradrenaline) by Type
1.3.1 Overview: Global Norepinephrine (Noradrenaline) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Norepinephrine (Noradrenaline) Consumption Value Market Share by Type in 2023
1.3.3 2mg
1.3.4 4mg
1.3.5 Other
1.4 Global Norepinephrine (Noradrenaline) Market by Application
1.4.1 Overview: Global Norepinephrine (Noradrenaline) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Shock Hypotensive
1.4.3 AMI Hypotension
1.4.4 Other
1.5 Global Norepinephrine (Noradrenaline) Market Size & Forecast
1.6 Global Norepinephrine (Noradrenaline) Market Size and Forecast by Region
1.6.1 Global Norepinephrine (Noradrenaline) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Norepinephrine (Noradrenaline) Market Size by Region, (2019-2030)
1.6.3 North America Norepinephrine (Noradrenaline) Market Size and Prospect (2019-2030)
1.6.4 Europe Norepinephrine (Noradrenaline) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Norepinephrine (Noradrenaline) Market Size and Prospect (2019-2030)
1.6.6 South America Norepinephrine (Noradrenaline) Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Norepinephrine (Noradrenaline) Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Norepinephrine (Noradrenaline) Product and Solutions
2.1.4 Pfizer Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Norepinephrine (Noradrenaline) Product and Solutions
2.2.4 Novartis Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Norepinephrine (Noradrenaline) Product and Solutions
2.3.4 Teva Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Recent Developments and Future Plans
2.4 Amneal Biosciences
2.4.1 Amneal Biosciences Details
2.4.2 Amneal Biosciences Major Business
2.4.3 Amneal Biosciences Norepinephrine (Noradrenaline) Product and Solutions
2.4.4 Amneal Biosciences Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Amneal Biosciences Recent Developments and Future Plans
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business
2.5.3 Baxter Norepinephrine (Noradrenaline) Product and Solutions
2.5.4 Baxter Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Baxter Recent Developments and Future Plans
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Norepinephrine (Noradrenaline) Product and Solutions
2.6.4 Mylan Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mylan Recent Developments and Future Plans
2.7 Hikma Pharmaceuticals
2.7.1 Hikma Pharmaceuticals Details
2.7.2 Hikma Pharmaceuticals Major Business
2.7.3 Hikma Pharmaceuticals Norepinephrine (Noradrenaline) Product and Solutions
2.7.4 Hikma Pharmaceuticals Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.8 Shanghai Harvest
2.8.1 Shanghai Harvest Details
2.8.2 Shanghai Harvest Major Business
2.8.3 Shanghai Harvest Norepinephrine (Noradrenaline) Product and Solutions
2.8.4 Shanghai Harvest Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Shanghai Harvest Recent Developments and Future Plans
2.9 Grand Pharmaceutical
2.9.1 Grand Pharmaceutical Details
2.9.2 Grand Pharmaceutical Major Business
2.9.3 Grand Pharmaceutical Norepinephrine (Noradrenaline) Product and Solutions
2.9.4 Grand Pharmaceutical Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Grand Pharmaceutical Recent Developments and Future Plans
2.10 King York
2.10.1 King York Details
2.10.2 King York Major Business
2.10.3 King York Norepinephrine (Noradrenaline) Product and Solutions
2.10.4 King York Norepinephrine (Noradrenaline) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 King York Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Norepinephrine (Noradrenaline) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Norepinephrine (Noradrenaline) by Company Revenue
3.2.2 Top 3 Norepinephrine (Noradrenaline) Players Market Share in 2023
3.2.3 Top 6 Norepinephrine (Noradrenaline) Players Market Share in 2023
3.3 Norepinephrine (Noradrenaline) Market: Overall Company Footprint Analysis
3.3.1 Norepinephrine (Noradrenaline) Market: Region Footprint
3.3.2 Norepinephrine (Noradrenaline) Market: Company Product Type Footprint
3.3.3 Norepinephrine (Noradrenaline) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Norepinephrine (Noradrenaline) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Norepinephrine (Noradrenaline) Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Norepinephrine (Noradrenaline) Consumption Value Market Share by Application (2019-2024)
5.2 Global Norepinephrine (Noradrenaline) Market Forecast by Application (2025-2030)
6 North America
6.1 North America Norepinephrine (Noradrenaline) Consumption Value by Type (2019-2030)
6.2 North America Norepinephrine (Noradrenaline) Market Size by Application (2019-2030)
6.3 North America Norepinephrine (Noradrenaline) Market Size by Country
6.3.1 North America Norepinephrine (Noradrenaline) Consumption Value by Country (2019-2030)
6.3.2 United States Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
6.3.3 Canada Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
6.3.4 Mexico Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Norepinephrine (Noradrenaline) Consumption Value by Type (2019-2030)
7.2 Europe Norepinephrine (Noradrenaline) Consumption Value by Application (2019-2030)
7.3 Europe Norepinephrine (Noradrenaline) Market Size by Country
7.3.1 Europe Norepinephrine (Noradrenaline) Consumption Value by Country (2019-2030)
7.3.2 Germany Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
7.3.3 France Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
7.3.5 Russia Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
7.3.6 Italy Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Norepinephrine (Noradrenaline) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Norepinephrine (Noradrenaline) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Norepinephrine (Noradrenaline) Market Size by Region
8.3.1 Asia-Pacific Norepinephrine (Noradrenaline) Consumption Value by Region (2019-2030)
8.3.2 China Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8.3.3 Japan Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8.3.4 South Korea Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8.3.5 India Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
8.3.7 Australia Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
9 South America
9.1 South America Norepinephrine (Noradrenaline) Consumption Value by Type (2019-2030)
9.2 South America Norepinephrine (Noradrenaline) Consumption Value by Application (2019-2030)
9.3 South America Norepinephrine (Noradrenaline) Market Size by Country
9.3.1 South America Norepinephrine (Noradrenaline) Consumption Value by Country (2019-2030)
9.3.2 Brazil Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
9.3.3 Argentina Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Norepinephrine (Noradrenaline) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Norepinephrine (Noradrenaline) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Norepinephrine (Noradrenaline) Market Size by Country
10.3.1 Middle East & Africa Norepinephrine (Noradrenaline) Consumption Value by Country (2019-2030)
10.3.2 Turkey Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
10.3.4 UAE Norepinephrine (Noradrenaline) Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Norepinephrine (Noradrenaline) Market Drivers
11.2 Norepinephrine (Noradrenaline) Market Restraints
11.3 Norepinephrine (Noradrenaline) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Norepinephrine (Noradrenaline) Industry Chain
12.2 Norepinephrine (Noradrenaline) Upstream Analysis
12.3 Norepinephrine (Noradrenaline) Midstream Analysis
12.4 Norepinephrine (Noradrenaline) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Pfizer
Novartis
Teva
Amneal Biosciences
Baxter
Mylan
Hikma Pharmaceuticals
Shanghai Harvest
Grand Pharmaceutical
King York

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂